A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
Novartis
AstraZeneca
University of Colorado, Denver
University of Alabama at Birmingham
Tempus AI
Memorial Sloan Kettering Cancer Center
Actuate Therapeutics Inc.
Dana-Farber Cancer Institute